RSV

Creator

Creator

Created

Created

2023 Jan 20 7:38

Editor

Editor

Edited

Edited

2023 May 5 15:53

Refs

Refs

호흡기세포융합바이러스

In a world first, RSV vaccine wins FDA approval for adults 60 and up

It's an achievement decades in the making, and more vaccines are in the pipeline.

In a world first, RSV vaccine wins FDA approval for adults 60 and up

https://arstechnica.com/science/2023/05/in-a-world-first-rsv-vaccines-wins-fda-approval-for-adults-60-and-up/

In a world first, RSV vaccine wins FDA approval for adults 60 and up

Why Pfizer’s RSV vaccine success is a big deal, decades in the making

Research on RSV vaccines dragged after a trial in the '60s went tragically wrong.

Why Pfizer’s RSV vaccine success is a big deal, decades in the making

https://arstechnica.com/science/2022/11/why-pfizers-rsv-vaccine-success-is-a-big-deal-decades-in-the-making

Why Pfizer’s RSV vaccine success is a big deal, decades in the making

Moderna's mRNA RSV vaccine delivers impressive Phase 3 trial results

Biotechnology company Moderna has announced promising results from its massive Phase 3 trial testing an mRNA vaccine for respiratory syncytial virus (RSV) in older adults. The data indicates the vaccine is nearly 84% effective at preventing moderate disease and the company expects to file for US...

Moderna's mRNA RSV vaccine delivers impressive Phase 3 trial results

https://newatlas.com/medical/moderna-mrna-rsv-vaccine-phase-3-trial-results

Moderna's mRNA RSV vaccine delivers impressive Phase 3 trial results

Recommendations

////////